OCS-05 in Patients With Optic Neuritis

NCT04762017 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Optic Neuritis

Interventions

DRUG: OCS-05 +SoC (corticosteroid) IV administration
OTHER: Placebo + SoC (corticosteroid) IV administration

Sponsor

Oculis

Collaborators

[object Object]